Oncostatin M and Nivolumab Affect the Cytotoxic T-Cell Proportions and the Susceptibility to TRAIL-Induced Death in Non-Leukocyte Cell Subpopulations in Soft Tissue Sarcomas.

Giulia Toffanin,Andrej Ozaniak,Robin Bartolini,Martin Komarc,Rene Novysedlak,Michal Rataj,Jitka Smetanova,Antonio Rosato,Robert Lischke,Jirina Bartunkova,Zuzana Strizova

Pharmacology（2023）

引用 0|浏览7

暂无评分

摘要

In conclusion, the biological efficacy of OSM is reflected in the tumor microenvironment rather than in the peripheral blood of the patients in our cohort, and nivolumab could potentiate its mechanism of action in selected cases. Nevertheless, more histotype-tailored studies are needed to fully understand the functions of OSM in STSs.

查看译文

关键词

Cytokines,Monoclonal antibody,Nivolumab,Oncostatin M,Soft tissue sarcomas,T cells,Tumor microenvironment

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要